Novavax Gets the Green Light—But With a Catch

Novavax’s COVID-19 vaccine just scored full FDA approval, but here’s the twist: it’s only for people 65+ or those 12–64 with health risks. Unlike Pfizer and Moderna, this protein-based shot isn’t for everyone yet—kids under 12 are still waiting on more data. The FDA’s also asking for more studies, especially on heart safety. If you’ve been holding out for a non-mRNA option, this could be your moment (if you qualify)! #Novavax #COVID19Vaccine #FDAApproval #HealthNews #VaccineUpdate #Health